Clinical trial
CP-481,715 Nickel Allergy Study.
NCT00141180 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141180 |
|---|---|
| Title | CP-481,715 Nickel Allergy Study. |
| Official title | Placebo-Controlled, Randomized, Parallel Group, Multiple-Dose Study to Evaluate the Effects of CP-481,715 on Clinical Response and Cellular Infiltration Following Contact Allergen Challenge to the Skin of Nickel Allergic Subjects. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Dermatitis, Allergic Contact |
| Intervention type | Drug |
| Interventions | CP-481, 715 |
| Enrollment | 48 |
| Start date | Sep 1, 2003 |
| Completion | Oct 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Jul 25, 2006 |
| Countries | Denmark, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: